Related references
Note: Only part of the references are listed.Surfactant protein D: A useful biomarker for distinguishing COVID-19 pneumonia from COVID-19 pneumonia-like diseases
Yuki Togashi et al.
HEALTH SCIENCE REPORTS (2022)
Baseline characteristics of COVID-19 Italian patients admitted to Desio Hospital, Lombardy: a retrospective study
Adela Sulejmani et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2021)
SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties
Alastair Watson et al.
FRONTIERS IN IMMUNOLOGY (2021)
Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019
Jose Alberto Choreno-Parra et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Serum surfactant protein D in COVID-19 is elevated and correlated with disease severity
Ming Tong et al.
BMC INFECTIOUS DISEASES (2021)
The role of angiopoietin-2 and surfactant protein-D levels in SARS-CoV-2-related lung injury: A prospective, observational, cohort study
Handan Alay et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2
Raquel Arroyo et al.
BIOMOLECULES (2021)
Extrapulmonary manifestations of COVID-19
Aakriti Gupta et al.
NATURE MEDICINE (2020)
Are Serum Interleukin 6 and Surfactant Protein D Levels Associated with the Clinical Course of COVID-19?
Bugra Kerget et al.
LUNG (2020)
Investigation of surfactant protein-D and interleukin-6 levels in patients with blunt chest trauma with multiple rib fractures and pulmonary contusions: a cross-sectional study in Black Sea Region of Turkey
Aysel Kurt et al.
BMJ OPEN (2016)
The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis
Tsukasa Okamoto et al.
RESPIRATORY MEDICINE (2015)
Serum Surfactant Protein D (SP-D) is a Prognostic Marker of Poor Outcome in Patients with A/H1N1 Virus Infection
Carlos Delgado et al.
LUNG (2015)
Lung Surfactant Protein D (SP-D) Response and Regulation During Acute and Chronic Lung Injury
Maria Quisgaard Gaunsbaek et al.
LUNG (2013)
Influenza A Viruses Target Type II Pneumocytes in the Human Lung
Viola K. Weinheimer et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Elevated Plasma Surfactant Protein D (SP-D) Levels and a Direct Correlation with Anti-severe Acute Respiratory Syndrome Coronavirus-specific IgG Antibody in SARS Patients
Y. P. Wu et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
S-Nitrosylation of Surfactant Protein-D Controls Inflammatory Function
Chang-Jiang Guo et al.
PLOS BIOLOGY (2008)
Surfactant protein D in human lung diseases
D Hartl et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury
MD Eisner et al.
THORAX (2003)
Diagnostic significance of surfactant proteins A and D in sera from patients with radiation pneumonitis
H Takahashi et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis
H Takahashi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)